Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reduced Intensity Conditioning Regimens

Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas

Bone Marrow Transplantation volume 30, pages 207–214 (2002)Cite this article

Abstract

The aim of this pilot study was to exploit the graft-versus-tumor potential of allogeneic transplants while improving safety of the procedure. Twelve patients with advanced hematological malignancies and solid tumors underwent a low intensity conditioning regimen (fludarabine and cyclophosphamide) followed by an allogeneic peripheral blood stem cell transplantation. The median time to achieve an absolute neutrophil count of more than 0.5 × 109/l and an untransfused platelet count of more than 20 × 109/l was 15 and 14 days, respectively. The main extra-hematological toxicities were mucositis and infections. Acute graft-versus-host (GVHD) disease was experienced by 62% of evaluable patients (grade II/B or III/C 80%) responsive to steroids. Extensive chronic GVHD was observed in 62% of patients. Non-relapse transplant-related mortality by day +30 was observed in three patients (25%). Eight out of 12 patients were full donor chimeric by day +100. One patient showed a mixed chimerism at day +37 when he died from progressive disease. One patient was in complete remission (CR) before allogeneic transplantation, and after transplantation four patients achieved CR and four experienced progressive disease. Our study confirms that a low intensity conditioning regimen for allogeneic stem cell transplantation is feasible and effective in heavily pretreated patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation New Engl J Med 2000 343: 750 758

    Article  CAS  PubMed  Google Scholar 

  2. Childs R ., Clave E., Contentin N et al. Engraftment kinetics after non myeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses Blood 1999 94: 3234 3241

    CAS  PubMed  Google Scholar 

  3. Ueno NT, Rondon G, Mirza NQ et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer J Clin Oncol 1998 16: 986 993

    Article  CAS  PubMed  Google Scholar 

  4. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041 2050

    CAS  PubMed  Google Scholar 

  5. Steis RG, Urba WJ, Kopp WC . Kinetics of recovery of CD4+ T cells in peripheral blood of deoxycoformycin-treated patients J Natl Cancer Inst 1991 83: 1678 1679

    Article  CAS  PubMed  Google Scholar 

  6. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft Br J Haematol 1994 87: 609 613

    Article  CAS  PubMed  Google Scholar 

  7. Arpinati M, Green CL, Haimfeld S et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood 2000 95: 2484 2490

    CAS  PubMed  Google Scholar 

  8. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease Blood 1995 86: 4422 4429

    CAS  PubMed  Google Scholar 

  9. Mielcarek M, Graf L, Johnson G, Torok-Storb B . Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation Blood 1998 92: 215 221

    CAS  PubMed  Google Scholar 

  10. Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenogastrim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Française de greffe de moelle J Clin Oncol 2000 18: 537 546

    Article  CAS  PubMed  Google Scholar 

  11. Powels R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial Lancet 2000 335: 1231 1237

    Article  Google Scholar 

  12. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1998 21: 995 1003

    Article  CAS  PubMed  Google Scholar 

  13. Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers New Engl J Med 2001 344: 175 181

    Article  CAS  PubMed  Google Scholar 

  14. Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 88: 2775 2779

    CAS  PubMed  Google Scholar 

  15. Rachamim N, Gan J, Segall H et al. Tolerance induction by ‘megadose’ hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture Transplantation 1998 65: 1386 1393

    Article  CAS  PubMed  Google Scholar 

  16. Petz LD, Yam P, Wallace RB et al. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies Blood 1987 70: 1331 1337

    CAS  PubMed  Google Scholar 

  17. Hill RS, Petersen FB, Storb R et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease Blood 1986 67: 811 816

    CAS  PubMed  Google Scholar 

  18. Mattsson J, Uzunel M, Remberger M, Ringden O . T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation Transplantation 2001 71: 433 439

    Article  CAS  PubMed  Google Scholar 

  19. McSweeney PA, Storb R . Mixed chimerism: preclinical studies and clinical applications Biol Blood Marrow Transplant 1999 5: 192 203

    Article  CAS  PubMed  Google Scholar 

  20. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295 304

    Article  CAS  PubMed  Google Scholar 

  21. Rowlings PA, Przepiorka D, Klein JP et al. IBMTR severity index for grading acute graft-versus-host disease : retrospective comparision with Glucksberg grade Br J Haematol 1997 97: 855 864

    Article  CAS  PubMed  Google Scholar 

  22. Hughes WT, Armstrong D, Bodey GP et al. Guidelines for the use of antimicrobial infectious agents in neutropenic patients with unexplained fever Clin Infect Dis 1997 25: 551 573

    Article  CAS  PubMed  Google Scholar 

  23. Feinstein L, Storb R . Nonmyeloablative hemopoietic cell transplantation Curr Op Oncol 2001 13: 95 100

    Article  CAS  Google Scholar 

  24. Barrett J, Childs R . Non-myeloablative stem cell transplants Br J Haematol 2000 111: 6 17

    Article  CAS  PubMed  Google Scholar 

  25. Champlin R ., Khouri I., Shimoni A. et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy Br J Haematol 2000 111: 18 29

    Article  CAS  PubMed  Google Scholar 

  26. Bornhauser M, Thiede C, Schuler U et al. Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin Bone Marrow Transplant 2000 26: 119 125

    Article  CAS  PubMed  Google Scholar 

  27. Nagler A, Slavin S, Varadi G et al. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma Bone Marrow Transplant 2000 25: 1021 1028

    Article  CAS  PubMed  Google Scholar 

  28. Anderlini P, Giralt S, Andersson B et al. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease Bone Marrow Transplant 2000 26: 615 620

    Article  CAS  PubMed  Google Scholar 

  29. Garban F, Attal M, Rossi JF et al Intergroupe Francophone du Myelome. Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation Leukemia 2001 15: 642 646

    Article  CAS  PubMed  Google Scholar 

  30. Badros A, Barlogie B, Morris C et al. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions Blood 2001 97: 2574 2579

    Article  CAS  PubMed  Google Scholar 

  31. Eibl B, Schwaighofer H, Nachbaur D et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer Blood 1996 88: 1501 1508

    CAS  PubMed  Google Scholar 

  32. Carella AM, Cavaliere M, Lerma E et al. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hemopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma J Clin Oncol 2000 23: 3918 3924

    Article  Google Scholar 

  33. Martino R, Caballero MD, Canals C et al. Reduced-intensity conditioning reduces the risk of sever infections after allogeneic peripheral blood stem cell transplantation Bone Marrow Transplant 2001 28: 341 347

    Article  CAS  PubMed  Google Scholar 

  34. Giralt S, Thall PF, Khouri I et al. : Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation Blood 2001 97: 631 637

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy

    L Castagna, A Bertuzzi, A Nozza, L Siracusano, M Balzarotti, M Magagnoli, B Sarina, I Timofeeva & A Santoro

  2. Centro Trasfusionale, Ospedale S Paolo, Milan, Italy

    M Sinnone

  3. Cytogenetic Laboratory, Ospedale Maggiore Policlinico, Milan, Italy

    MG Grimoldi

  4. Centro Trasfusionale e di Immunoematologia, Istituto Ortopedico Gaetano Pini, Milan, Italy

    M Farè

Authors
  1. L Castagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Bertuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Nozza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Siracusano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Balzarotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Magagnoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B Sarina
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I Timofeeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Sinnone
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. MG Grimoldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Farè
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Santoro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castagna, L., Bertuzzi, A., Nozza, A. et al. Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. Bone Marrow Transplant 30, 207–214 (2002). https://doi.org/10.1038/sj.bmt.1703626

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703626

Keywords

Search

Advanced search

Quick links